Core Viewpoint - Prestige Consumer Healthcare Inc. is set to release its fiscal 2026 third quarter earnings on February 5, 2026, before market opening, followed by a conference call at 8:30 a.m. ET to discuss the results [1]. Group 1: Earnings Release and Conference Call - The earnings release for fiscal 2026 third quarter will be issued on February 5, 2026, before the market opens [1]. - A conference call to discuss the earnings results will take place on the same day at 8:30 a.m. ET [1]. - Participants can access the live Internet webcast from the Investor Relations page of the company's website [2]. Group 2: Conference Call Participation - Participants can register for the conference call to receive dial-in details and a unique pin, with a recommendation to join 10 minutes early [2]. - A replay of the conference call will be available for approximately one week following the live event [3]. Group 3: ICR Conference Participation - The company will participate in a fireside chat at the 28th Annual ICR Conference on January 13, 2026, at 9:30 a.m. ET [4]. - A live audio webcast of the ICR Conference event can be accessed from the Investor Relations page of the company's website [4]. - A replay of the webcast will be available later the same day [4]. Group 4: Company Overview - Prestige Consumer Healthcare is a leading consumer healthcare products company with sales in the U.S., Canada, Australia, and other international markets [5]. - The company's diverse portfolio includes brands such as Monistat®, Summer's Eve®, BC®, Goody's®, Clear Eyes®, TheraTears®, and many others [5].

Core Points - Prestige Consumer Healthcare Inc. will release its fiscal 2026 second quarter and first half earnings on November 6, 2025, before market opening [1] - A conference call to discuss the earnings results will take place on the same day at 8:30 a.m. ET [1] Company Overview - Prestige Consumer Healthcare Inc. markets, sells, manufactures, and distributes consumer healthcare products across the U.S., Canada, Australia, and other international markets [4] - The company's product portfolio includes brands such as Monistat®, Summer's Eve®, BC®, Goody's®, Clear Eyes®, TheraTears®, DenTek®, Dramamine®, Fleet®, Chloraseptic®, Luden's®, Compound W®, Little Remedies®, Boudreaux's Butt Paste®, Nix®, Debrox®, Gaviscon®, Hydralyte®, and Fess® [4]

Group 1 - Prestige Consumer Healthcare Inc. will present at the Barclays Global Consumer Staples Conference on September 4, 2025, at 12:45 p.m. ET [1] - Interested parties can access a live webcast of the event on the company's website under the "Investors" section [1] - A replay option will be available on the company's website for those unable to participate in the live webcast [1] Group 2 - Prestige Consumer Healthcare is a leading consumer healthcare products company with sales in the U.S., Canada, Australia, and other international markets [2] - The company's diverse portfolio includes brands such as Monistat®, Summer's Eve®, BC®, Goody's®, Clear Eyes®, TheraTears®, DenTek®, Dramamine®, Fleet®, Chloraseptic®, Luden's®, Compound W®, Little Remedies®, Boudreaux's Butt Paste®, Nix®, Debrox®, Gaviscon®, Hydralyte®, and Fess® [2]